Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Recent & Breaking News (NDAQ:LEXX)

Lexaria Bioscience Announces new DehydraTECH Innovation, Files New Patents

Accesswire June 4, 2019

Lexaria Bioscience Corp. Featured in CannabisNewsAudio Broadcast Touting Impact of Technology on CBD Edible Space

GlobeNewswire May 31, 2019

Lexaria Bioscience Corp. Featured in CannabisNewsWire Publication Discussing Disruptive Potential of CBD Delivery Technology

GlobeNewswire May 30, 2019

Combining Lexaria's DehydraTECH(TM) with Nanotech Delivers Increased Quantities of CBD into Brain Tissue

TheNewsWire May 28, 2019

Combining Lexaria's DehydraTECHTM with Nanotech Delivers Increased Quantities of CBD into Brain Tissue

Accesswire May 28, 2019

Lexaria Bioscience Announces the Issuance of Options and Warrants

TheNewsWire May 23, 2019

Lexaria Bioscience and Nuka Enterprises' 1906 Expand Cannabis Product Relationship

TheNewsWire May 21, 2019

Lexaria's DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations

TheNewsWire May 15, 2019

Lexaria's DehydraTECH Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations

Accesswire May 15, 2019

Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company

TheNewsWire May 7, 2019

Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company

Accesswire May 7, 2019

Lexaria Bioscience Expands Advisory Board

Accesswire April 25, 2019

Lexaria Bioscience Expands Advisory Board

TheNewsWire April 25, 2019

Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company

TheNewsWire April 24, 2019

Lexaria Bioscience Announces Further Details on Oak Hill Financial Inc. Engagement

TheNewsWire April 16, 2019

Lexaria Bioscience Engages Oak Hill Financial Inc. to Provide Investor Relations Services

Accesswire April 15, 2019

Lexaria Bioscience Renews Contracts with Senior Management and Cancels Options

Accesswire April 9, 2019

BTV Highlights 5 Companies Spearheading Innovation

Newsfile March 28, 2019

Lexaria Bioscience Corp., Ingesting Instead of Inhaling Could Save 60,000 Lives a Year, CEO Clip Video

Newsfile March 22, 2019

Lexaria Bioscience Begins Largest Cannabinoid R&D Program in its History

Accesswire March 20, 2019